News
Hosted on MSN5mon
Hims & Hers stock tumbles after Novo's semaglutide taken off shortage list (update)Shares of Hims & Hers (NYSE:HIMS) fell 15% Wednesday following news that Novo Nordisk’s (NVO) weight-loss drug Wegovy is ... that the agency had taken tizepatide off the list too soon and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback